To address your questions about pathway enrichment analysis as described in the scientific article, let's break down each point based on typical practices and the specific details provided: 1. **Tool Used for Pathway Enrichment Analysis:** - The article does not explicitly mention a specific tool used for pathway enrichment analysis. 2. **Tool Version Number Provided:** - Not described in the article. There is no mention of any version number related to tools. 3. **Gene Set Library Queried (e.g., GO, KEGG, Reactome, or other):** - The article does not specify which gene set library was queried for pathway enrichment analysis. 4. **Background Gene List Defined for Pathway Enrichment Analysis:** - Not described in the article. There is no information provided about a background gene list being defined. 5. **Statistical Test Used for Enrichment Analysis:** - The specific statistical test used for enrichment analysis is not detailed in the article. 6. **False Discovery Rate Correction:** - It is not mentioned whether false discovery rate (FDR) correction was employed to control the number of false positives in the pathway enrichment analysis. Based on these observations, here's a summary table: | Question | Answer | |---------------------------------------------------------------|----------------| | Tool used for pathway enrichment analysis | Not described | | Tool version number provided | Not described | | Gene set library queried (e.g., GO, KEGG, Reactome) | Not described | | Background gene list defined | Not described | | Statistical test used for enrichment analysis | Not described | | False discovery rate correction | Not described | If you have access to the full text or supplementary materials of the article, there might be additional details that are not covered in the abstract or sections typically summarized.